An entrepreneur and CEO with more than two decades of experience in the medical cannabis, biotechnology, pharmaceutical, nutraceutical, and medical device industries, Christina’s dedication to revolutionizing patient care is unprecedented. Through her roles as CEO, Spectral Analytics Precision Tele-Monitoring, Founder and CEO of Affinity Bio Partners, Board President and CEO of Affinity Patient Advocacy, and CEO & Co-Founder of AI Health Outcomes, Christina has been involved with revolutionary projects and global clinical studies that positively impact patients.
Christina was a participant in Season 2 of the “Four Days to Save the World” TV Series that will be released on Earth Day 2022.
As a clinical research pioneer, contracts negotiator, Opinion Columnist for CEO WorldBiz and has a Podcast, I am Christina DiArcangelo, she has utilized the tools at her disposal to champion patient care and provide best-in-class patient advocacy services. For Christina, patient care comes first.
As an active Bahai’ and mother to her one son, Christian, she believes that listening, learning, and growing are everyday values that can change the world by impacting our own hearts, homes, and communities.
Founded in November 2014, in a transition from Christina DiArcangelo’s previous company Armonia Clinical Research (first formed in 2009), ABP represents the world’s leading cutting-edge Clinical Research Organization (CRO). Affinity Bio Partners LLC endeavors to provide integral enterprise-wide solutions that facilitate the development of drugs, biologics, natraceuticals and medical devices. ABP provides services such as, but not limited too:
Groundbreaking Medical Marijuana and Cannabinoid Clinical Research activities
Clinical Research Operations and Product Marketing
Enterprise-wide Strategic Planning Solutions
Enterprise-wide Governance Solutions
Asset Procurement and Staffing Solutions
Advance clinical outsourcing to improve the quality, efficiency and safety of biomedical research.
Conducting clinical trials in domestic and international settings while ensuring the safety of research participants.
Strengthen public understanding and confidence in clinical research, highlighting CRO expertise in all aspects of the clinical research enterprise.